Privia Health Files 8-K for Regulatory Disclosure
Ticker: PRVA · Form: 8-K · Filed: Jun 5, 2024 · CIK: 1759655
| Field | Detail |
|---|---|
| Company | Privia Health Group, Inc. (PRVA) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, sec-filing
Related Tickers: PRVA
TL;DR
PRVA filed a routine 8-K, no major news.
AI Summary
Privia Health Group, Inc. filed an 8-K on June 5, 2024, to disclose information under Regulation FD and to file financial statements and exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form type.
Why It Matters
This filing serves as a standard regulatory update, indicating Privia Health is meeting its disclosure obligations with the SEC.
Risk Assessment
Risk Level: low — The filing is a standard regulatory disclosure and does not contain any new material information that would impact risk.
Key Players & Entities
- Privia Health Group, Inc. (company) — Registrant
- June 5, 2024 (date) — Date of earliest event reported
- 950 N. Glebe Rd., Suite 700 (address) — Principal Executive Offices
- Arlington, Virginia (location) — Principal Executive Offices Location
FAQ
What is the primary purpose of this 8-K filing by Privia Health Group, Inc.?
The primary purpose is to provide a Regulation FD Disclosure and to file Financial Statements and Exhibits.
On what date was this 8-K report filed or deemed filed?
The report was filed as of June 5, 2024.
What is the exact name of the company filing this report?
The exact name of the registrant is Privia Health Group, Inc.
Where are Privia Health Group, Inc.'s principal executive offices located?
The principal executive offices are located at 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203.
Does this filing indicate any specific new material events or financial results?
No, the filing indicates it is for Regulation FD Disclosure and Financial Statements and Exhibits, which are standard reporting items and do not inherently disclose new material events or specific financial results in this summary.
Filing Stats: 622 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-06-05 07:00:41
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Glo
Filing Documents
- prva-20240605.htm (8-K) — 26KB
- prvawmblairpresentation-.htm (EX-99.1) — 19KB
- prvawmblairpresentation-001.jpg (GRAPHIC) — 72KB
- prvawmblairpresentation-002.jpg (GRAPHIC) — 204KB
- prvawmblairpresentation-003.jpg (GRAPHIC) — 73KB
- prvawmblairpresentation-004.jpg (GRAPHIC) — 82KB
- prvawmblairpresentation-005.jpg (GRAPHIC) — 87KB
- prvawmblairpresentation-006.jpg (GRAPHIC) — 76KB
- prvawmblairpresentation-007.jpg (GRAPHIC) — 69KB
- prvawmblairpresentation-008.jpg (GRAPHIC) — 74KB
- prvawmblairpresentation-009.jpg (GRAPHIC) — 100KB
- prvawmblairpresentation-010.jpg (GRAPHIC) — 96KB
- prvawmblairpresentation-011.jpg (GRAPHIC) — 98KB
- prvawmblairpresentation-012.jpg (GRAPHIC) — 95KB
- prvawmblairpresentation-013.jpg (GRAPHIC) — 77KB
- prvawmblairpresentation-014.jpg (GRAPHIC) — 81KB
- prvawmblairpresentation-015.jpg (GRAPHIC) — 48KB
- prvawmblairpresentation-016.jpg (GRAPHIC) — 103KB
- prvawmblairpresentation-017.jpg (GRAPHIC) — 74KB
- prvawmblairpresentation-018.jpg (GRAPHIC) — 34KB
- prvawmblairpresentation-019.jpg (GRAPHIC) — 90KB
- prvawmblairpresentation-020.jpg (GRAPHIC) — 93KB
- prvawmblairpresentation-021.jpg (GRAPHIC) — 53KB
- prvawmblairpresentation-022.jpg (GRAPHIC) — 61KB
- prvawmblairpresentation-023.jpg (GRAPHIC) — 62KB
- prvawmblairpresentation-024.jpg (GRAPHIC) — 75KB
- prvawmblairpresentation-025.jpg (GRAPHIC) — 75KB
- 0001759655-24-000106.txt ( ) — 3004KB
- prva-20240605.xsd (EX-101.SCH) — 2KB
- prva-20240605_lab.xml (EX-101.LAB) — 22KB
- prva-20240605_pre.xml (EX-101.PRE) — 13KB
- prva-20240605_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. We are furnishing this Current Report on Form 8-K to furnish materials that will be provided at meetings with institutional investors or analysts. The materials are attached as Exhibit 99.1 to this Current Report on Form 8-K, are incorporated into this Item 7.01 by reference and are available on our investor relations website at ir.priviahealth.com . This information may be amended or updated at any time and from time to time through another Current Report on Form 8-K, a later company filing, or other means. The information in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. By filing this Current Report on Form 8-K and furnishing this information, the Company makes no admission as to the materiality of any information contained in this Current Report (including Exhibit 99.1), that is required to be disclosed solely by Regulation FD. We do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any change in events, conditions, or circumstances on which any forward-looking statement is based.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibit: Exhibit No. Description 99.1 Privia Health Group, Inc. Investor Presentation Slides - June 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRIVIA HEALTH GROUP, INC. Date: June 5, 2024 By: /s/ David Mountcastle Name: David Mountcastle Title: Executive Vice President, Chief Financial Officer and Authorized Officer